News
SOPH
5.07
+2.22%
0.11
SOPHiA GENETICS Is Maintained at Buy by BTIG
Dow Jones · 13h ago
BTIG Maintains Buy on Sophia Genetics, Raises Price Target to $8
Benzinga · 13h ago
Sophia Genetics price target raised to $8 from $7 at BTIG
TipRanks · 13h ago
Weekly Report: what happened at SOPH last week (0406-0410)?
Weekly Report · 2d ago
Analysts Offer Insights on Healthcare Companies: SOPHiA GENETICS (SOPH) and Certara (CERT)
TipRanks · 5d ago
Sophia Genetics management to meet with Craig-Hallum
TipRanks · 04/08 15:55
Sophia Genetics management to meet with BTIG
TipRanks · 04/06 18:45
Weekly Report: what happened at SOPH last week (0330-0403)?
Weekly Report · 04/06 09:15
Weekly Report: what happened at SOPH last week (0323-0327)?
Weekly Report · 03/30 09:15
Sophia Genetics management to meet with Piper Sandler
TipRanks · 03/26 17:35
Sophia Genetics management to meet with Piper Sandler
TipRanks · 03/24 14:40
Weekly Report: what happened at SOPH last week (0316-0320)?
Weekly Report · 03/23 09:14
Weekly Report: what happened at SOPH last week (0309-0313)?
Weekly Report · 03/16 09:14
Weekly Report: what happened at SOPH last week (0302-0306)?
Weekly Report · 03/09 09:14
Sophia Genetics Earnings Call: Growth Surges, Losses Linger
TipRanks · 03/09 00:08
SOPHiA GENETICS (SOPH) Q4 Loss Deepens And Reinforces Bearish Profitability Concerns
Simply Wall St · 03/05 00:54
SOPHiA GENETICS: Clear Growth Inflection, Improving Margins, and Path to 2026 Profitability Support Buy Rating
TipRanks · 03/04 10:56
Analysts Offer Insights on Healthcare Companies: SOPHiA GENETICS (SOPH) and Evolus (EOLS)
TipRanks · 03/04 03:50
Sophia Genetics files to sell 75,000 ordinary shares for holders
TipRanks · 03/03 21:26
Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH), SOPHiA GENETICS (SOPH) and InfuSystem Holdings (INFU)
TipRanks · 03/03 15:11
More
Webull provides a variety of real-time SOPH stock news. You can receive the latest news about Sophia Genetics Sa through multiple platforms. This information may help you make smarter investment decisions.
About SOPH
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.